CLW

Clearwater Paper Corp. 10-Q Summary: Q2 2025

Business Context and Reporting Period

This report covers the quarterly period ended June 30, 2025. Clearwater Paper Corporation is a manufacturer of bleached paperboard servicing independent converters in North America. The company operates as a single segment following the sale of its tissue (consumer products) division in November 2024, which is now reported as discontinued operations. The company completed the acquisition of the Augusta, Georgia paperboard facility on May 1, 2024, which is fully integrated into current results.

Key Financial Metrics

Liquidity: As of June 30, 2025, the company had $46.7 million in cash. Under the ABL Credit Agreement, borrowing base availability was $245.1 million, with $50.7 million utilized ($47.0M borrowings + $3.7M letters of credit).

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 14% in Q2 and 28% YTD compared to 2024, driven primarily by volume increases from the Augusta acquisition. This was partially offset by market-driven price decreases (sales price per ton down 2.8% in Q2).
• Profitability: The company returned to profitability in Q2 2025 ($2.7M net income) compared to a loss of $25.8M in Q2 2024. This improvement is largely due to the absence of the tissue division's losses in 2024 (now discontinued) and improved operating performance in continuing operations.
• Cost Structure: Cost of sales increased 1% in Q2 and 21% YTD. Input costs rose due to higher volumes and energy/chemical costs, though fiber costs were lower. Labor and overhead decreased in Q2 due to cost reduction plans and maintenance timing.
• Cash Flow: Operating cash flow turned negative YTD 2025 (-$26.7M) compared to positive $80.3M in 2024. This was driven by a $57.2M payment of 2024 income tax liabilities related to the tissue sale and lower operating performance in the remaining business.

Guidance, Outlook, and Risks

• Outlook: Management expects Q3 2025 sales volumes to be flat compared to Q2. Energy costs are expected to decrease seasonally, offset by increased planned major maintenance expenses at the Lewiston, Idaho mill.
• Tariffs: The company is evaluating the impact of new U.S. tariffs (10% baseline, plus country-specific rates on Canada/Mexico). While exemptions currently apply to some raw materials, potential increases to 35% (Canada) and 30% (Mexico) effective August 1 are being monitored. Management does not currently expect a significant impact on fiscal 2025 results but notes uncertainty.
• Cost Reduction: A cost reduction plan announced in early 2025 targets $5M to $7M in severance costs by year-end. $5.1M has been incurred YTD.
• Legal Contingencies:
  • Augusta Acquisition Claim: The company submitted a claim in July 2025 to its representation and warranty insurance carrier regarding alleged breaches in the Augusta acquisition. No recovery has been recognized as of June 30, 2025.
  • PFAS Litigation: Named as a defendant in an environmental lawsuit in Georgia regarding PFAS in water supplies. The company intends to vigorously defend the claim.

Investor Verification Checklist

• Augusta Integration: Verify the realization of synergies and the finalization of the purchase price allocation for the Augusta facility.
• Tariff Exposure: Assess the potential financial impact of the announced tariff increases on Canada and Mexico effective August 1, 2025, specifically regarding raw material costs.
• Insurance Claim Status: Monitor the status of the representation and warranty insurance claim related to the Augusta acquisition.
• Working Capital: Review the $19.2 million accrued liability related to the tissue divestiture working capital adjustment and the $20.1 million collected under the transition services agreement to be remitted in Q3.
• Capital Expenditures: Confirm adherence to the projected $80M-$90M capital expenditure budget for 2025.